EUCTR2010-020404-29-CZ进行中（未招募）不适用
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diabetes - N/A
Eli Lilly and Company Limited, Indianapolis0 个研究点目标入组 400 人开始时间: 2011年3月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and women not of childbearing potential =25 years of age with type 1 or type 2 diabetes mellitus and either an SCr of 1.3 to 3.3 mg/dL (115 to 291 µmol/L) in women and 1.5 to 3.5 mg/dL (132 to 309 µmol/L) in men, or an estimated glomerular filtration rate (eGFR) of 20 to 60 mL/min/1.73m2, and a 24-hour urine PCR of =800 mg/g (=91 mg/mmol), despite equilibration for =2 months on an appropriate dose of either ACEi or ARB therapy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Chronic kidney disease (CKD) from causes other than presumed DKD, uncontrolled hypertension, unstable cardiovascular disease, cancer or predisposing conditions, autoimmune disease, chronic inflammatory disease, hepatitis B or C infection, cirrhosis or significant liver disease, systemic immunosuppression therapy, and recent gastrointestinal bleeding.
研究者
相似试验
进行中（未招募）
不适用
A study in Patients with Diabetic Kidney DiseasePatients with Diabetic Kidney Disease due to Type 1 or Type 2 DiabetesMedDRA version: 15.0Level: LLTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-020404-29-HUEli Lilly and Company Limited, Indianapolis400
进行中（未招募）
2 期
Study of safety and efficacy of UNR844 in subjects with presbyopiaPresbyopiaJPRN-jRCT2051210054Yamada Hiroyuki45
进行中（未招募）
不适用
A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion.Ensayo multicéntrico, con doble enmascaramiento, controlado con placebo y aleatorizado de la inyección intravítrea de microplasmina para el tratamiento no quirúrgico de la adherencia vitreomacular focal.Focal Vitreomacular AdhesionAdherencia Vitreomacular FocalMedDRA version: 9.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeEUCTR2008-004393-40-ESThromboGenics NV320
进行中（未招募）
不适用
A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion.Focal Vitreomacular AdhesionMedDRA version: 9.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeEUCTR2008-004393-40-BEThromboGenics NV320
进行中（未招募）
不适用
A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion.EUCTR2008-004393-40-DEThromboGenics NV320